New hope for tough lymphomas: experimental drug shows promise in Mid-Stage trial
NCT ID NCT04842877
First seen Feb 23, 2026 · Last updated Jun 18, 2026 · Updated 22 times
Summary
This study tests an experimental drug called valemetostat tosylate in people with B-cell lymphoma whose cancer has returned or not responded to prior treatments. About 141 participants will receive the drug to see if it can shrink tumors. The goal is to find a new option for hard-to-treat lymphomas.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.Z. Sint Jan AV
Bruges, 8000, Belgium
-
CH Tourelle Peltzer
Verviers, 4800, Belgium
-
CH d'Avignon
Avignon, 84000, France
-
CH de la Côte Basque
Bayonne, 64109, France
-
CHU Hôtel Dieu
Nantes, 44093, France
-
CHU Mont-Godinne
Yvoir, Belgium
-
CHU Pontchaillou
Rennes, 35003, France
-
CHU d'Estaing
Clermont-Ferrand, 63000, France
-
CHU de Dijon
Dijon, 21034, France
-
CHU de Montpellier
Montpellier, 34295, France
-
Ch Metropole Savoie - Site Chambery
Chambéry, 73000, France
-
Ch de Bretagne Atlantique -
Vannes, 56017, France
-
Chd de Vendee
La Roche-sur-Yon, 85925, France
-
Clinique Victor Hugo
Le Mans, 72000, France
-
Emmanuel Bachy
Pierre-Bénite, 69495, France
-
François Lemonnier
Créteil, 94010, France
-
Gh Region Mulhouse Et Sud Alsace
Mulhouse, 68070, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Paoli Calmette
Marseille, 13273, France
-
Institut d'Hématologie de Basse Normandie
Caen, 14076, France
-
Service des Maladies du Sang - CHRU de Lille
Lille, 59037, France
-
University Hospital Gent
Ghent, 9000, Belgium
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.